Investors might want to keep an eye on developments at Numeral Ltd

The anger and frustration displayed by Bonitas members is in stark contrast to the distinct lack of urgency from the authorities

With healthcare costs rising and medical aids under pressure, gap cover fills a growing financial hole – but take-up remains stubbornly low

Discovery’s ham-fisted efforts to recoup money paid in error to some members is a lesson in how not to manage a crisis

Drones are playing a productive role in Africa, plugging the many service and infrastructure gaps that exist

A major contract dispute will slash Aspen’s profits. Investors are rattled – and confidence in the company is ebbing away

USAID-funded projects focused on HIV prevention and treatment, including TB programmes, received termination letters overnight

The least favourite part of Aspen CEO Stephen Saad’s job, it seems, is delivering the firm’s twice-yearly results presentations. It’s hard to blame him this time around, given…